Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.
Buruli ulcer, caused by infection with Mycobacterium ulcerans, is a necrotizing disease of the skin and subcutaneous tissue, which is most prevalent in rural regions of West African countries. The majority of clinical presentations seen in patients are ulcers on limbs that can be treated by eight we...
Main Authors: | Miriam Bolz, Sarah Kerber, Gert Zimmer, Gerd Pluschke |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4537091?pdf=render |
Similar Items
-
Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.
by: Miriam Bolz, et al.
Published: (2016-02-01) -
Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.
by: Raphael Bieri, et al.
Published: (2016-02-01) -
Experimental infection of the pig with Mycobacterium ulcerans: a novel model for studying the pathogenesis of Buruli ulcer disease.
by: Miriam Bolz, et al.
Published: (2014-07-01) -
Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates.
by: Angèle Bénard, et al.
Published: (2016-01-01) -
Introduction of Mycobacterium ulcerans disease in the Bankim Health District of Cameroon follows damming of the Mapé River.
by: Koen Vandelannoote, et al.
Published: (2020-09-01)